Literature DB >> 9297586

Detection of triazolam in skeletal remains buried for 4 years.

K Kudo1, H Sugie, N Syoui, K Kurihara, N Jitsufuchi, T Imamura, N Ikeda.   

Abstract

Analyses of the hypnotic triazolam from the remains of two human skeletons buried underground for 4 years were made for purposes of confirmation. The bone marrow and mummified muscle were digested with 2 M sodium hydroxide, efficiently extracted using a 3-step solvent extraction procedure, and selectively analyzed by gas chromatography/mass spectrometry with the negative ion chemical ionization mode. Estazolam was the internal standard used. Triazolam was detected in all the samples; the concentrations were 0.36 ng/g in the bone marrow of one victim, and 0.37 and 5.5 ng/g in the bone marrow and mummified muscle of the other victim. This method should prove useful for determination of triazolam in extensively decomposed bodies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9297586     DOI: 10.1007/s004140050086

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  4 in total

Review 1.  State-of-the-art of bone marrow analysis in forensic toxicology: a review.

Authors:  Nathalie Cartiser; Fabien Bévalot; Laurent Fanton; Yvan Gaillard; Jérôme Guitton
Journal:  Int J Legal Med       Date:  2011-03       Impact factor: 2.686

2.  Using bone marrow matrix to analyze meprobamate for forensic toxicological purposes.

Authors:  F Bévalot; M P Gustin; N Cartiser; Y Gaillard; C Le Meur; L Fanton; J Guitton; D Malicier
Journal:  Int J Legal Med       Date:  2013-02-12       Impact factor: 2.686

3.  Detecting drugs in dry bone: a pilot study of skeletal remains with a post-mortem interval over 23 years.

Authors:  Gaia Giordano; Lucie Biehler-Gomez; Pierfausto Seneci; Cristina Cattaneo; Domenico Di Candia
Journal:  Int J Legal Med       Date:  2021-01-02       Impact factor: 2.686

4.  Reconstruction of a case of thallium poisoning using LA-ICP-SFMS.

Authors:  Stephan Hann; Christopher Latkoczy; Thomas L Bereuter; Thomas Prohaska; Gerhard Stingeder; Christian Reiter
Journal:  Int J Legal Med       Date:  2004-07-09       Impact factor: 2.686

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.